Testing medications to protect small blood vessels in the brain

This trial is testing whether a combination of medications—including cilostazol, isosorbide mononitrate, and standard antiplatelet drugs like aspirin or clopidogrel—can better protect the tiny blood vessels in your brain and prevent future strokes. Small vessel disease is a common condition where these small blood vessels become damaged or weakened, often causing mini-strokes that you might not even notice at first. Researchers want to see if this medication combination is safer and more effective than standard treatments alone.

Right now, doctors don't have a proven best treatment for small vessel disease of the brain, especially when it comes to preventing repeat strokes. Some current approaches (like using two antiplatelet drugs together) can actually increase the risk of dangerous brain bleeding in these patients. This trial exists to find a safer, more effective approach that targets the root problem—damaged blood vessel linings—rather than just thinning the blood.